SCHEMBL13065009

SCHEMBL13065009

O=C(c1cccc(N(Cc2ccc(Cl)cc2)S(=O)(=O)c2ccccc2)c1)N1CCC(c2ccccn2)CC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.50
KMT2A Q03164 2/20 0.49
HPGD P15428 2/20 0.49
MEN1 O00255 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
MAPT P10636 1/20 0.47
PKM P14618 2/20 0.47
CNR2 P34972 2/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HSD17B10 Q99714 1/20 0.43
HSD11B1 P28845 1/20 0.42
CNR1 P21554 1/20 0.41
CYP3A4 P08684 1/20 0.41
SPR P35270 1/20 0.41
ABL1 P00519 1/20 0.41
BCR P11274 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065213 0.91 LMNA (0.57) LMNAKMT2AHPGDMEN1SMN1; SMN2
SCHEMBL13065011 0.88 LMNA (0.55) LMNAKMT2AHPGDMEN1SMN1; SMN2
SCHEMBL13064397 0.87 PKM (0.47) LMNAKMT2AHPGDMEN1SMN1; SMN2
SCHEMBL13064395 0.85 SMN1; SMN2 (0.63) LMNAKMT2AHPGDMEN1SMN1; SMN2
SCHEMBL13065033 0.84 LMNA (0.59) LMNAKMT2AHPGDSMN1; SMN2MAPT
SCHEMBL13064516 0.84 LMNA (0.60) LMNAKMT2AHPGDMEN1SMN1; SMN2
SCHEMBL13065202 0.83 CNR2 (0.60) LMNAKMT2AHPGDMEN1SMN1; SMN2
SCHEMBL13065200 0.82 LMNA (0.52) LMNAKMT2AHPGDMEN1SMN1; SMN2
SCHEMBL13065010 0.82 HTR2B (0.51) LMNAKMT2AHPGDMEN1
SCHEMBL303313 0.81 LMNA (0.57) LMNAKMT2AHPGDMEN1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010130638-A1 SULFONAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF EVOTEC AG (DE) 2010-11-18 WO disclosed